Search Results - "Spira, Rosemary Dray"

Refine Results
  1. 1

    Risk of severe COVID‐19 in patients treated with IBD medications: a French nationwide study by Meyer, Antoine, Semenzato, Laura, Zureik, Mahmoud, Weill, Alain, Carbonnel, Franck, DraySpira, Rosemary

    Published in Alimentary pharmacology & therapeutics (01-07-2021)
    “…Summary Background Recently, the SECURE‐IBD study, based on a physician‐reported registry, suggested that thiopurines, either alone or combined with anti‐TNF,…”
    Get full text
    Journal Article
  2. 2

    Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010‐2018 by Meyer, Antoine, Drouin, Jérôme, Weill, Alain, Carbonnel, Franck, DraySpira, Rosemary

    Published in Alimentary pharmacology & therapeutics (01-11-2020)
    “…Summary Background Inflammatory bowel disease (IBD) most commonly occurs in young adults, including women of child‐bearing age. Aim To describe pregnancy in…”
    Get full text
    Journal Article
  3. 3

    Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study by Hoisnard, Lea, Meyer, Antoine, DraySpira, Rosemary, Weill, Alain, Zureik, Mahmoud, Sbidian, Emilie

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2024)
    “…Objective To compare the risk of gastrointestinal perforation (GIP), a rare but serious adverse event, in patients who a JAK inhibitor (JAKi; tofacitinib,…”
    Get full text
    Journal Article
  4. 4

    Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti‐TNF: a French nationwide study 2010–2018 by Meyer, Antoine, Drouin, Jérôme, Weill, Alain, Carbonnel, Franck, DraySpira, Rosemary

    Published in Alimentary pharmacology & therapeutics (01-08-2021)
    “…Summary Background Data about thiopurines or anti‐TNF use during pregnancy in women with inflammatory bowel diseases (IBD) are reassuring. However, many…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G‐CSF support: A nationwide population‐based cohort by Jabagi, Marie Joelle, Vey, Norbert, Goncalves, Anthony, Le Tri, Thien, Zureik, Mahmoud, Drayspira, Rosemary

    Published in International journal of cancer (15-01-2021)
    “…Our study aimed to analyze the risk of hematologic malignancies (HM) associated with the use of G‐CSF with chemotherapy for BC. Using the French National…”
    Get full text
    Journal Article
  9. 9

    Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study by Roland, Noémie, Baricault, Bérangère, DraySpira, Rosemary, Weill, Alain, Duranteau, Lise, Zureik, Mahmoud

    “…Objective To assess the user profiles of copper intrauterine devices (Cu‐IUD) and levonorgestrel intrauterine systems (LNG‐IUS) in France in 2019 and the rates…”
    Get full text
    Journal Article
  10. 10

    Social determinants in prenatal antidepressant use and continuation: Systematic review and meta‐analysis by Marr, Ketevan, Maguet, Charlotte, Scarlett, Honor, DraySpira, Rosemary, Dubertret, Caroline, Gressier, Florence, Sutter‐Dallay, Anne‐Laure, Melchior, Maria, van der Waerden, Judith

    Published in Acta psychiatrica Scandinavica (01-11-2024)
    “…Introduction Depression is one of the most common co‐morbidities during pregnancy; with severe symptoms, antidepressants are sometimes recommended. Social…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury by Coste, Joël, Karras, Alexandre, Rudnichi, Annie, DraySpira, Rosemary, Pouchot, Jacques, Giral, Philippe, Zureik, Mahmoud

    Published in Pharmacoepidemiology and drug safety (01-12-2019)
    “…Purpose To investigate the risk of acute kidney injury (AKI) in subjects initiating statin therapy for primary prevention of cardiovascular disease (CVD)…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Spatio‐temporal changes in pre‐exposure prophylaxis uptake among MSM in mainland France between 2016 and 2021: a Bayesian small area approach with MSM population estimation by Wang, Haoyi, Molina, Jean‐Michel, DraySpira, Rosemary, Schmidt, Axel J., Hickson, Ford, Vijver, David, Jonas, Kai J.

    Published in Journal of the International AIDS Society (01-05-2023)
    “…Introduction In France, oral pre‐exposure prophylaxis (PrEP) for HIV prevention has been publicly available since 2016, mainly targeting at men who have sex…”
    Get full text
    Journal Article
  16. 16

    Response to “On the risk of using raw regional data on new HIV infections in France” by Tassi et al by Wang, Haoyi, Molina, Jean‐Michel, DraySpira, Rosemary, Schmidt, Axel J., Hickson, Ford, Vijver, David van de, Jonas, Kai J.

    Published in Journal of the International AIDS Society (01-01-2024)
    “…[...]we employed Bayesian spatial analysis as an indirect approach to model the regional risk of newly diagnosed HIV, based on EMIS-2017 data, as a spatial…”
    Get full text
    Journal Article
  17. 17

    Access to health insurance coverage among sub-Saharan African migrants living in France: Results of the ANRS-PARCOURS study by Vignier, Nicolas, Desgrées du Loû, Annabel, Pannetier, Julie, Ravalihasy, Andrainolo, Gosselin, Anne, Lert, France, Lydié, Nathalie, Bouchaud, Olivier, Dray Spira, Rosemary

    Published in PloS one (15-02-2018)
    “…Migrants' access to care depends on their health insurance coverage in the host country. We aimed to evaluate in France the dynamic and the determinants of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease by Botton, Jérémie, Semenzato, Laura, Dupouy, Julie, DraySpira, Rosemary, Weill, Alain, Saint‐Lary, Olivier, Zureik, Mahmoud

    “…Aspirin at low doses has been reported to be a potential drug candidate to treat or prevent severe coronavirus disease 2019 (COVID‐19). We aimed to explore…”
    Get full text
    Journal Article
  20. 20

    Timing of chronic hepatitis B diagnosis after migration and its determinants among Sub-Saharan African migrants living in France by Pannetier, Julie, Gigonzac, Virginie, Lydié, Nathalie, Desgrées du Loû, Annabel, Dray Spira, Rosemary

    Published in PloS one (28-12-2017)
    “…In European countries, chronic hepatitis B (CHB) disproportionately affects migrants from medium- and high-endemic areas and is largely underdiagnosed. To…”
    Get full text
    Journal Article